Stem cell trials focus on fixing hearts

03/22/2007 | MIT Technology Review

Studies have offered mixed results on the benefits of stem cell therapy to treat heart disease, pointing out that to be effective there needs to be knowledge of which cells to transplant and when and how to prepare and deliver them. In a new trial focusing on patients who've not responded to other treatment, a specific blood-forming stem cell will be injected directly into the heart. One expert said that learning how to heal a damaged heart "could revolutionize cardiology."

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA